Article

Comprehensive Analysis of METTLs (METTL1/13/18/21A/23/25/2A/2B/5/6/9) and Associated mRNA…

Analytical Cellular Pathology · 2023 · Haoyu Wang, author Shangshang Hu, author Junjie Nie, author Xiaodan Qin, author Xu Zhang, author Qian Wang, author John Zhong Li, author Yun Ping Lim, Academic Editor

Key facts

Title Comprehensive Analysis of METTLs (METTL1/13/18/21A/23/25/2A/2B/5/6/9) and Associated mRNA Risk Signature in Hepatocellular Carcinoma
First author Haoyu Wang, author Shangshang Hu, author Junjie Nie, author Xiaodan Qin, author Xu Zhang, author Qian Wang, author John Zhong Li, author Yun Ping Lim, Academic Editor
Journal Analytical Cellular Pathology
Published Feb 24, 2023
DOI 10.1155/2023/6007431
Devices mentioned 203454, 204170

At a glance

  • 1–9 FDA submissions mentioned
  • None Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature